Deferoxamine mimics the pattern of hypoxia-related injury at the microvasculature

Shock

Volumn 31, Issue 5, 2009, Pages 481-485

  Bartolome, Sonja ^a   Dhillon, Navneet K ^b   Buch, Shilpa ^b   Casillan, Alfred J ^b   Wood, John G ^b   O'Brien Ladner, Amy R ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Deferoxamine; Intravital microscopy; Reactive oxygen species

Indexed keywords

DEFEROXAMINE; HYPOXIA INDUCIBLE FACTOR; OXYGEN; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; HEART INFARCTION; HYPOXIA; IRON CHELATION; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; MALE; MICROSCOPY; MICROVASCULATURE; NONHUMAN; PROTEIN TARGETING; RAT; STROKE; TISSUE INJURY; ANIMAL; ANOXIA; CAPILLARY PERMEABILITY; CELL ADHESION; CELL MOTION; CYTOLOGY; DRUG EFFECT; LEUKOCYTE; METABOLISM; MICROCIRCULATION; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANOXIA; CAPILLARY PERMEABILITY; CELL ADHESION; CELL MOVEMENT; DEFEROXAMINE; LEUKOCYTES; MALE; MICROCIRCULATION; MICROVESSELS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

EID: 67649383518     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e318188db14     Document Type: Article

References (28)

1. Duranteau J, Chandel NS, Kulisz A, Shao Z, Schumacker PT: Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J Biol Chem 273:11619-11624, 1998.
2. Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC, Schumacker PT: Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci U S A 95:11715-11720, 1998.
3. Lu GW, Yu S, Li RH, Cui XY, Gao CY: Hypoxic preconditioning: a novel intrinsic cytoprotective strategy. Mol Neurobiol 31:255-271, 2005.
4. Ratan RR, Siddiq A, Smirnova N, Karpisheva K, Haskew-Layton R, McConoughey S, Langley B, Estevez A, Huerta PT, Volpe B, et al.: Harnessing hypoxic adaptation to prevent, treat, and repair stroke. J Mol Med (Berlin, Germany) 85:1331-1338, 2007.
5. Zamudio S, Kovalenko O, Vanderlelie J, Illsley NP, Heller D, Belliappa S, Perkins AV: Chronic hypoxia in vivo reduces placental oxidative stress. Placenta 2007.
6. Wood JG, Johnson JS, Mattioli LF, Gonzalez NC: Systemic hypoxia promotes leukocyte-endothelial adherence via reactive oxidant generation. J Appl Physiol 87:1734-1740, 1999.
7. Wood JG, Johnson JS, Mattioli LF, Gonzalez NC: Systemic hypoxia increases leukocyte emigration and vascular permeability in conscious rats. J Appl Physiol 89:1561-1568, 2000.
8. Steiner DR, Gonzalez NC, Wood JG: Interaction between reactive oxygen species and nitric oxide in the microvascular response to systemic hypoxia. J Appl Physiol 93:1411-1418, 2002.
9. Lee JW, Bae SH, Jeong JW, Kim SH, Kim KW: Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp Mol Med 36:1-12, 2004.
10. Hirsila M, Koivunen P, Xu L, Seeley T, Kivirikko KI, Myllyharju J: Effect of desferrioxamine and metals on the hydroxylases in the oxygen sensing pathway. FASEB J 19:1308-1310, 2005.
11. Balanos GM, Dorrington KL, Robbins PA: Desferrioxamine elevates pulmonary vascular resistance in humans: potential for involvement of HIF-1. J Appl Physiol 92:2501-2507, 2002.
12. Dendorfer A, Heidbreder M, Hellwig-Burgel T, Johren O, Qadri F, Dominiak P: Deferoxamine induces prolonged cardiac preconditioning via accumulation of oxygen radicals. Free Radic Biol Med 38:117-124, 2005.
13. Ren X, Dorrington KL, Maxwell PH, Robbins PA: Effects of desferrioxamine on serum erythropoietin and ventilatory sensitivity to hypoxia in humans. J Appl Physiol 89:680-686, 2000.
14. Hamrick SE, McQuillen PS, Jiang X, Mu D, Madan A, Ferriero DM: A role for hypoxia-inducible factor-1alpha in desferoxamine neuroprotection. Neurosci Lett 379:96-100, 2005.
15. Prass K, Ruscher K, Karsch M, Isaev N, Megow D, Priller J, Scharff A, Dirnagl U, Meisel A: Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J Cereb Blood Flow Metab 22:520-525, 2002.
16. O'Brien-Ladner AR, Blumer BM, Wesselius LJ: Differential regulation of human alveolar macrophage-derived interleukin-1beta and tumor necrosis factor-alpha by iron: J Lab Clin Med 132:497-506, 1998.
17. O'Brien-Ladner AR, Nelson SR, Murphy WJ, Blumer BM, Wesselius LJ: Iron is a regulatory component of human IL-1beta production. Support for regional variability in the lung. Am J Respir Cell Mol Biol 23:112-119, 2000.
18. Steiner DR, Gonzalez NC, Wood JG: Mast cells mediate the microvascular inflammatory response to systemic hypoxia. J Appl Physiol 94:325-334, 2003.
19. Vengellur A, Phillips JM, Hogenesch JB, LaPres JJ: Gene expression profiling of hypoxia signaling in human hepatocellular carcinoma cells. Physiol Genomics 22:308-318, 2005.
20. Creighton-Gutteridge M, Tyrrell RM: A novel iron chelator that does not induce HIF-1 activity. Free Radic Biol Med 33:356-363, 2002.
21. Mu D, Chang YS, Vexler ZS, Ferriero DM: Hypoxia-inducible factor 1alpha and erythropoietin upregulation with deferoxamine salvage after neonatal stroke. Exp Neurol 195:407-415, 2005.
22. Wang GL, Semenza GL: Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 82:3610-3615, 1993.
23. Packer L, Witt EH, Tritschler HJ: alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med 19:227-250, 1995.
24. Aust SD, Morehouse LA, Thomas CE: Role of metals in oxygen radical reactions. J Free Radic Biol Med 1:3-25, 1985.
25. Winterbourn CC: Toxicity of iron and hydrogen peroxide: the Fenton reaction. Toxicol Lett 82-83:969-974, 1995.
26. Davies MJ, Donkor R, Dunster CA, Gee CA, Jonas S, Willson RL: Desferrioxamine (Desferal) and superoxide free radicals. Formation of an enzyme-damaging nitroxide. Biochem J 246:725-729, 1987.
27. Niihara Y, Shalev O, Hebbel RP, Wu H, Tu A, Akiyama DS, Tanaka KR: Desferrioxamine (DFO) conjugated with starch decreases NAD redox potential of intact red blood cells (RBC): evidence for DFO as an extracellular inducer of oxidant stress in RBC. Am J Hematol 65:281-284, 2000.
28. Blake DR, Hall ND, Bacon PA, Dieppe PA, Halliwell B, Gutteridge JM: Effect of a specific iron chelating agent on animal models of inflammation. Ann Rheum Dis 42:89-93, 2002.